A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group. Glioblastoma is the most common brain cancer, and […]Continue Reading ...
WEDNESDAY, Oct. 10, 2018 — Halobetasol propionate 0.01 percent lotion (BRYHALI Lotion) appears safe and effective for the treatment of moderate-to-severe plaque psoriasis, according to the results of two phase 3 trials published in the October issue of the Journal of Drugs in Dermatology. Lawrence J. Green, M.D., from George Washington University in Washington, D.C., […]Continue Reading ...
Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer, the most common malignancy among American men. Developed by a panel of experts from […]Continue Reading ...
A new article in the Journal of the National Cancer Institute finds that some cancer patients appear to benefit more from exercise than others. Exercise interventions during primary cancer treatment, especially chemotherapy, typically aim to prevent declines in functioning and to reduce treatment side-effects, while exercise interventions after treatment aim to improve functioning. There is […]Continue Reading ...
A housing subsidy treatment that enables low-income families in US cities to move from public to private housing appears to reduce adolescent girls’ binge drinking but increase adolescent boys’ binge drinking. The reasons for these differential gender effects are not yet clear. Affordable housing policies are common in democratic nations, and the Housing Choice Voucher […]Continue Reading ...
WOODCLIFF LAKE, N.J., Sept. 28, 2018 /PRNewswire/ — Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) expanded the indication of its antiepileptic drug Fycompa (perampanel) CIII for monotherapy and adjunctive use in pediatric patients 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures. […]Continue Reading ...
FDA Approves Tegsedi (inotersen) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis BOSTON and CARLSBAD, Calif., Oct. 05, 2018 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today that the U.S. Food and Drug Administration (FDA) has approved Tegsedi (inotersen) […]Continue Reading ...
A robot could become the ‘weapon’ of choice for detecting and treating the most common cancer in men, improving results and reducing side effects. Scientists and mathematicians in the UK, Netherlands and France are working on a potentially game-changing way of improving the accuracy of both prostate cancer biopsies and of brachytherapy, which is used […]Continue Reading ...
For the third time since 2013, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined in an early benefit assessment the added benefit of the drug pertuzumab in the treatment of HER2-positive breast cancer. The monoclonal antibody is always used in combination with trastuzumab and chemotherapy. Whereas the first two benefit assessments […]Continue Reading ...
REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (NASDAQ: MNLO) a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated with various conditions, today announced top-line results from MTI-110 (TUSSIX), its Phase 2 clinical trial of serlopitant for the treatment of refractory chronic cough. In […]Continue Reading ...
CoreChoice, the national specialty network for radiology, interventional pain management, and medical air transportation services is pleased to announce their partnership agreement with MINES & Associates to form the nation’s first PPO network solution to combat the nationwide opioid and polysubstance use epidemic. The network contains 24,000 providers nationwide consisting of inpatient treatment centers, outpatient […]Continue Reading ...
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors. This achievement, to be reported at the ESMO 2018 Congress in Munich, shows that cutting-edge precision medicine is spreading from highly specialist cancer units to […]Continue Reading ...
Data from a clinical trial has shown that how people respond to treatment for Bipolar Disorder may be influenced by their weight and the overall quality of their diet, including whether they are eating a diet high in foods thought to contribute to general inflammation. These are early results, but if replicated may mean that […]Continue Reading ...
A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease. Professor Patricia Kissinger and a team of researchers found the recommended single dose of medication isn’t enough to eliminate trichomoniasis, the most common curable STD, […]Continue Reading ...
FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne Barcelona – 2nd October 2018 — Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived oral antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris […]Continue Reading ...
- Scientists uncover possible new causes of Tourette syndrome
- Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
- Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
- Elective induction of labor at 39 weeks may be beneficial option for women and their babies
- New smart watch algorithms can accurately monitor wearers’ sleep patterns
- Researchers demonstrate epigenetic memory transmission via sperm
- FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
- Health Tip: Know the Risks of Chicken Pox
- Immunotherapy effective against hereditary melanoma
- Researchers reveal new mechanism for how animal cells stay intact | News Center
- Alzheimer's Goes Under the Cryo-Electron Microscope
- Medicare for all? CMS chief warns program has enough problems already
- Metrohm Raman introduces Mira P handheld Raman system
- Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
- Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
- Many healthy children may have metabolic risk factors, finds study
- A new antibiotic could be a better, faster treatment for tuberculosis
- “I will not become a Robot Doctor”: A medical student vows to practice compassion
- Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
- Purdue researchers develop new chemical process to find better drug ‘fits’ for patients